|
|
|
 |
 |
 |
| Reviews |
 |
| Phosphorylation of Bcl2 and regulation of apoptosis FREE |
| P P Ruvolo, X Deng & W S May |
| Abstract | Full text | PDF |
|
| 515 |
 |
| Gene therapy: principles and applications to hematopoietic cells FREE |
| V F I Van Tendeloo, C Van Broeckhoven & Z N Berneman |
| Abstract | Full text | PDF |
|
| 523 |
 |
| Gene-based cancer vaccines: an ex vivo approach FREE |
| V F I Van Tendeloo, C Van Broeckhoven & Z N Berneman |
| Abstract | Full text | PDF |
|
| 545 |
 |
| Original Manuscripts |
 |
| Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure FREE |
| N Radosevic, A Delmer, R Tang, J-P Marie & F Ajchenbaum-Cymbalista |
| Abstract | Full text | PDF |
|
| 559 |
 |
| Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation FREE |
| Z Cai, M Lin, C Wuchter, V Ruppert, B Dörken, W-D Ludwig & L Karawajew |
| Abstract | Full text | PDF |
|
| 567 |
 |
| ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL FREE |
| P J Shteper, Z Siegfried, F A Asimakopoulos, G A Palumbo, E A Rachmilewitz, Y Ben-Neriah & D Ben-Yehuda |
| Abstract | Full text | PDF |
|
| 575 |
 |
| The diagnostic significance of Myf-3 hypermethylation in malignant lymphoproliferative disorders FREE |
| J M E Taylor, P H Kay & D V Spagnolo |
| Abstract | Full text | PDF |
|
| 583 |
 |
| Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells FREE |
| Y Kawaguchi, I Jinnai, K Nagai, F Yagasaki, Y Yakata, T Matsuo, K Kuriyama & M Tomonaga |
| Abstract | Full text | PDF |
|
| 590 |
 |
| Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5' MLL sequences in chromosome 4 FREE |
| A von Bergh, P Gargallo, B De Prijck, H Vranckx, R Marschalek, I Larripa, Ph Kluin, E Schuuring & A Hagemeijer |
| Abstract | Full text | PDF |
|
| 595 |
 |
| Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity FREE |
| K M Lin, W-G Zhao, J Bhatnagar, W-D Zhao, J-P Lu, S Simko, A Schueneman & G E Austin |
| Abstract | Full text | PDF |
|
| 601 |
 |
| Potentiatied antitumor effectiveness of combined chemo-immunotherapy with Interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo FREE |
J Go b, R Zago d on, R Kami ski, K Kozar, K Gryska, D I ycki, A Mackiewicz, T Stok osa, A Giermasz, W Lasek & M Jakóbisiak |
| Abstract | Full text | PDF |
|
| 613 |
 |
| Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2 FREE |
| S P M A Oomen, E G R Lichtenauer-Kaligis, N Verplanke, J Hofland, S W J Lamberts, B Löwenberg & I P Touw |
| Abstract | Full text | PDF |
|
| 621 |
 |
| Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene FREE |
| M-S Mateo, M Mollejo, R Villuendas, P Algara, M Sanchez-Beato, P Martínez & M A Piris |
| Abstract | Full text | PDF |
|
| 628 |
 |
| Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma FREE |
| M Mitterbauer, P Neumeister, P Kalhs, S Brugger, G Fischer, K Dieckmann, P Hoecker, W Hinterberger, W Linkesch, I Simonitsch, U Jaeger, K Lechner, C Mannhalter, G Mitterbauer & H T Greinix |
| Abstract | Full text | PDF |
|
| 635 |
 |
| Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation FREE |
| F Garban, M Attal, J F Rossi, C Payen, N Fegueux & J J Sotto on behalf of the Intergroupe Francophone du Myelome |
| Abstract | Full text | PDF |
|
| 642 |
 |
| Meeting Report |
 |
| HTLV Molecular Biology and Pathogenesis: Airlie Center, Warrenton, VA, USA, 17-19 March 2000 FREE |
| Z N Berneman |
| Abstract | Full text | PDF |
|
| 647 |
 |
| Acute Leukemia Forum 2000 |
 |
| Introduction FREE |
| Jacob M Rowe |
| Abstract | Full text | PDF |
|
| 655 |
 |
| Introduction of Ernest Beutler, MD FREE |
| M A Lichtman |
| Abstract | Full text | PDF |
|
| 656 |
 |
| The treatment of acute leukemia: past, present, and future FREE |
| E Beutler |
| Abstract | Full text | PDF |
|
| 658 |
 |
| Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia? FREE |
| R Storb |
| Abstract | Full text | PDF |
|
| 662 |
 |
AML1/CBF transcription complex: its role in normal hematopoiesis and leukemia FREE |
| J R Downing |
| Abstract | Full text | PDF |
|
| 664 |
 |
| MDR modulation in acute myelogenous leukemia: is it dead? FREE |
| J E Karp |
| Abstract | Full text | PDF |
|
| 666 |
 |
| Potential for therapy with AML-derived dendritic cells FREE |
| D Claxton & A Choudhury |
| Abstract | Full text | PDF |
|
| 668 |
 |
| Prognostic factors in acute myelogenous leukemia FREE |
| E H Estey |
| Abstract | Full text | PDF |
|
| 670 |
 |
| Small molecule mimics of hematopoietic growth factors: improving on Mother Nature? FREE |
| K Kaushansky |
| Abstract | Full text | PDF |
|
| 673 |
 |
| New agents for induction and postremission therapy of acute myeloid leukemia FREE |
| R A Larson |
| Abstract | Full text | PDF |
|
| 675 |
 |
| Uncertainties in the standard care of acute myelogenous leukemia FREE |
| J M Rowe |
| Abstract | Full text | PDF |
|
| 677 |
 |
| Who should be transplanted for AML? FREE |
| F R Appelbaum |
| Abstract | Full text | PDF |
|
| 680 |
 |
| Management of patients refractory to platelet transfusion FREE |
| C A Schiffer |
| Abstract | Full text | PDF |
|
| 683 |
 |
| Marrow vs peripheral blood: impact on transplant outcome FREE |
| S J Forman |
| Abstract | Full text | PDF |
|
| 686 |
 |
| Abnormalities of the CEBP alpha transcription factor: a major target in acute myeloid leukemia FREE |
| D G Tenen |
| Abstract | Full text | PDF |
|
| 688 |
 |
| Targeted AML therapy: new biologic paradigms and therapeutic opportunities FREE |
| C L Willman |
| Abstract | Full text | PDF |
|
| 690 |
 |
| Correspondence |
 |
| Simultaneous occurrence of bcr-abl and inv16 in a case of M1 acute myeloid leukemia FREE |
| M Svaldi, A Lanthaler, R Venturi, P Coser & M Mitterer |
| Abstract | Full text | PDF |
|
| 695 |
 |
| Synergistic effects of verapamil and anti-mdr1 ribozyme on reversion of multidrug resistance in the P-glycoprotein-positive K562 cell line FREE |
| Y Gong, W Han, J Liu, F Chen, J Han, Y Jin & R Ou Yong |
| Abstract | Full text | PDF |
|
| 696 |
 |
| Cytarabine-induced aseptic meningitis FREE |
| H van den Berg, M van der Flier & Md van de Wetering |
| Abstract | Full text | PDF |
|
| 697 |
 |
 |
 |
| April 2001, Volume 15, Number 4 |
 |
| <Previous Issue Next > |